REFERENCES
- Aminoff, M. J. (2006). Treatment should not be initiated too soon in Parkinson's disease. Annals of Neurology, 59, 562–564.
- Clarke, C. E. (2008). Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed? Movement Disorders, 23, 784–789.
- Happe, S., & Berger, K. (2001). The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease–a prospective study. Journal of Neurology, 248, 1062–1067.
- Hauser, R. A., Lew, M. F., Hurtig, H. I., Ondo, W. G., Wojcieszek, J., & Fitzer-Attas, C. J. (2009). Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. Movement Disorders, 24, 564–573.
- Miyasaki, J. M., Martin, W., Suchowersky, O., Weiner, W. J., & Lang. A. E. (2002). Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review: Report of the quality standards subcommittee of the American academy of neurology. Neurology, 58, 11–17.
- Nirenberg, M. J., & Waters, C. (2006). Compulsive eating and weight gain related to dopamine agonist use. Movement Disorders, 21, 524–529.
- O’Sullivan, S. S., Evans, A. H., & Lees A.J. (2009). Dopamine dysregulation syndrome: An overview of its epidemiology, mechanisms and management. CNS Drugs, 23, 157–170.
- Parkinson Study Group. (2002). A controlled trial of rasagiline in early Parkinson disease: The TEMPO Study. Archives of Neurology, 59, 1937–1943.
- Parkinson Study Group. (2004). A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Archives of Neurology, 61, 561–566.
- Schapira, A. H. V., & Obeso, J. (2006). Timing of treatment initiation in Parkinson's disease: A need for reappraisal? Annals of Neurology, 59, 559–562.
- Voon, V., Hassan, K., Zurowski, M., de Souza, M., Thomsen, T., Fox, S., (2006). Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology, 67, 1254–1257.
- Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E. (2006). Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology, 63, 969–973.